Lensar (LNSR) Interest Expenses (2019 - 2020)
Lensar (LNSR) reported Interest Expenses of $65000.0 for Q3 2020, down 86.84% year-over-year from $494000.0 in Q4 2019, and down 90.31% on a QoQ basis from $671000.0 in Q2 2020.
Lensar (LNSR) has 2 years of Interest Expenses data on file, last reported at $65000.0 in Q3 2020.
- Quarterly Interest Expenses fell 86.84% year-over-year to $65000.0 in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $65000.0 (down 97.2% YoY) and the FY2020 annual result came in at $1.3 million, down 33.03% from the prior year.
- Interest Expenses retreated to $65000.0 in Q3 2020 per LNSR's latest filing, from $671000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $671000.0 in Q2 2020 and bottomed at $65000.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 65,000.00 |
| Sep 30, 2020 | 65,000.00 |
| Jun 30, 2020 | 671,000.00 |
| Jun 30, 2020 | 671,000.00 |
| Mar 31, 2020 | 604,000.00 |
| Mar 31, 2020 | 604,000.00 |
| Dec 31, 2019 | 554,000.00 |
| Dec 31, 2019 | 554,000.00 |
| Sep 30, 2019 | 494,000.00 |
| Sep 30, 2019 | 494,000.00 |